Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis.
Rosar F, Burgard C, Larsen E, Khreish F, Marlowe RJ, Schaefer-Schuler A, Maus S, Petto S, Bartholomä M, Ezziddin S. Rosar F, et al. Among authors: marlowe rj. Cancer Imaging. 2024 Feb 22;24(1):27. doi: 10.1186/s40644-024-00671-1. Cancer Imaging. 2024. PMID: 38389092 Free PMC article.
Outstanding increase in tumor-to-background ratio over time allows tumor localization by [89Zr]Zr-PSMA-617 PET/CT in early biochemical recurrence of prostate cancer.
Burgard C, Rosar F, Larsen E, Khreish F, Linxweiler J, Marlowe RJ, Schaefer-Schuler A, Maus S, Petto S, Bartholomä M, Ezziddin S. Burgard C, et al. Among authors: marlowe rj. Cancer Imaging. 2024 Oct 7;24(1):132. doi: 10.1186/s40644-024-00778-5. Cancer Imaging. 2024. PMID: 39375762 Free PMC article.
Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations.
Burgard C, Rosar F, Marlowe RJ, Bartholomä M, Dewes S, Schaefer-Schuler A, Linxweiler J, Khreish F, Ezziddin S. Burgard C, et al. Among authors: marlowe rj. Cancers (Basel). 2023 May 3;15(9):2592. doi: 10.3390/cancers15092592. Cancers (Basel). 2023. PMID: 37174058 Free PMC article.
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence.
Reinecke MJ, Ahlers G, Burchert A, Eilsberger F, Flux GD, Marlowe RJ, Mueller HH, Reiners C, Rohde F, van Santen HM, Luster M. Reinecke MJ, et al. Among authors: marlowe rj. Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3247-3256. doi: 10.1007/s00259-022-05762-4. Epub 2022 Mar 23. Eur J Nucl Med Mol Imaging. 2022. PMID: 35320386 Free PMC article. Review.
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study).
Khreish F, Ghazal Z, Marlowe RJ, Rosar F, Sabet A, Maus S, Linxweiler J, Bartholomä M, Ezziddin S. Khreish F, et al. Among authors: marlowe rj. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1075-1085. doi: 10.1007/s00259-021-05525-7. Epub 2021 Sep 7. Eur J Nucl Med Mol Imaging. 2022. PMID: 34494131 Free PMC article.
35 results